Literature DB >> 27501473

Admission hyperglycemia in sepsis is associated with poor outcomes: where do we go from here?

Paul M Szumita1, James F Gilmore1.   

Abstract

Entities:  

Year:  2016        PMID： 27501473      PMCID： PMC4958787          DOI： 10.21037/jtd.2016.05.17

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

Review 1.  Management of diabetes and hyperglycemia in hospitals.

Authors:  Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Authors:  Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2009 May-Jun       Impact factor: 3.443

3.  (13) Diabetes care in the hospital, nursing home, and skilled nursing facility.

Authors: 
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

Review 4.  The future is now: software-guided intensive insulin therapy in the critically ill.

Authors:  Rishi Rattan; Stanley A Nasraway
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

5.  Target attainment through algorithm design during intravenous insulin infusion.

Authors:  Radha Devi; Tatheer Zohra; Bradley S Howard; Susan S Braithwaite
Journal:  Diabetes Technol Ther       Date:  2013-12-19       Impact factor: 6.118

Review 6.  Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.

Authors:  Judith Jacobi; Nicholas Bircher; James Krinsley; Michael Agus; Susan S Braithwaite; Clifford Deutschman; Amado X Freire; Douglas Geehan; Benjamin Kohl; Stanley A Nasraway; Mark Rigby; Karen Sands; Lynn Schallom; Beth Taylor; Guillermo Umpierrez; John Mazuski; Holger Schunemann
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

7.  Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host Response.

Authors:  Lonneke A van Vught; Maryse A Wiewel; Peter M C Klein Klouwenberg; Arie J Hoogendijk; Brendon P Scicluna; David S Y Ong; Olaf L Cremer; Janneke Horn; Marc M J Bonten; Marcus J Schultz; Tom van der Poll
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

8.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

Authors:  James Stephen Krinsley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

9.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

10.  Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study.

Authors:  Roosmarijn T M van Hooijdonk; Jan Hendrik Leopold; Tineke Winters; Jan M Binnekade; Nicole P Juffermans; Janneke Horn; Johan C Fischer; Edmée C van Dongen-Lases; Marcus J Schultz
Journal:  Crit Care       Date:  2015-02-05       Impact factor: 9.097
View more
  1 in total

1.  Hyperglycemia minimally alters primary self-renewing human colonic epithelial cells while TNFα-promotes severe intestinal epithelial dysfunction.

Authors:  Johanna S Dutton; Samuel S Hinman; Raehyun Kim; Peter J Attayek; Mallory Maurer; Christopher S Sims; Nancy L Allbritton
Journal:  Integr Biol (Camb)       Date:  2021-06-15       Impact factor: 2.192
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.